Initial Direct Oral Anticoagulants Versus Warfarin After Cerebral Venous Thrombosis: A Target Trial Emulation.

Supports starting a DOAC, here mostly rivaroxaban, rather than warfarin within 30 days of cerebral venous thrombosis, on observational non-inferiority data.

Highlights

EvidenceRetrospective cohort
What to watch: On a separate question, ESCORT (NCT06583889) randomises endovascular treatment against medical care in venous sinus thrombosis; estimated primary completion January 2029.

Open at Stroke ↗

Index entry — verify clinical detail against the primary source.

Related conditions

iih-venous

For learning and professional reference; not a patient-specific recommendation. How we prepare content.